Page last updated: 2024-11-02

pd 98059 and Heart Diseases

pd 98059 has been researched along with Heart Diseases in 2 studies

2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.

Heart Diseases: Pathological conditions involving the HEART including its structural and functional abnormalities.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bopassa, JC1
Eghbali, M1
Toro, L1
Stefani, E1
Chen, MM1
Lam, A1
Abraham, JA1
Schreiner, GF1
Joly, AH1

Other Studies

2 other studies available for pd 98059 and Heart Diseases

ArticleYear
A novel estrogen receptor GPER inhibits mitochondria permeability transition pore opening and protects the heart against ischemia-reperfusion injury.
    American journal of physiology. Heart and circulatory physiology, 2010, Volume: 298, Issue:1

    Topics: Adenosine Triphosphate; Animals; Blotting, Western; Enzyme Inhibitors; Extracellular Signal-Regulate

2010
CTGF expression is induced by TGF- beta in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis.
    Journal of molecular and cellular cardiology, 2000, Volume: 32, Issue:10

    Topics: Adult; Aged; Animals; Animals, Newborn; Biomarkers; Blotting, Northern; Cells, Cultured; Colforsin;

2000